Skip to content

Trans-perineal Ultrasound Guided Pudendal Nerve Block and Post-Hemorrhoidectomy Voiding complications

Trans-perineal Ultrasound Guided Pudendal Nerve Block and Post-Hemorrhoidectomy Voiding complications - US pudendal nerve block for Post-Hemorrhoidectomy Voiding complications

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000054259
Enrollment
68
Registered
2024-04-25
Start date
2024-04-10
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The study will include adult patients of both gender, suffering of hemorrhoids grade 3-4 and planned open hemorrhoidectomy (Milligan-Morgan hemorrhoidectomy) under general anesthesia.

Interventions

While the patient is in lithotomy position, US guided pudendal nerve block will be eprformed using bupivecaine 0.25 % 5 ml on each side perineal local anesthetic infiltration( lidocaine 1% 10 ml).

Sponsors

King Khalid University-Abha-Asir-KSA
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: adult patients of both gender, suffering of hemorrhoids grade 3-4 and planned open hemorrhoidectomy (Milligan-Morgan hemorrhoidectomy) under general anesthesia

Exclusion criteria

Exclusion criteria: Patients with known allergy to bupivacaine, redo surgery, preoperative voiding problems, prostatic hyperplasia, neurological disease affecting voiding control or patient ability to communicate will be excluded from the study.

Design outcomes

Primary

MeasureTime frame
the incidence of post-haemorhdectomy urinary retentin (primary outcome) measured in the irst 24 hours after surgery

Secondary

MeasureTime frame
Secondary variables will include; postoperative pain scores, postoperative voiding symptoms, postoperative analgesia consumption.

Countries

Asia(except Japan)

Contacts

Public ContactAlrefaey Alrefaey

Mansoura University- Egypt Anestheia department

refa3ey2@mans.edu.eg00201064203475

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026